SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2006 Commission File #2-89616 CONSOLIDATED MEDICAL MANAGEMENT, INC. (Exact name of registrant as specified in its charter) MONTANA (State or other jurisdiction of incorporation or organization) 82-0369233 (IRS Employer Identification Number) 11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816 (Address of principal executive offices)(Zip Code) 225-291-2239 (Registrant's telephone no., including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant is a shell company as defined by 12b-2. Yes [ ] The number of shares outstanding of the Company's common stock as of June 30, 2006 is shown below: Title of Class Number of Shares Outstanding Common Stock, par value $.001 per share 44,544,361. Documents Incorporated by Reference: None CONSOLIDATED MEDICAL MANAGEMENT, INC. FORM 10-QSB Table of Contents PART I - FINANCIAL INFORMATION Item 1 - Financial Information Item 2 - Management's Discussion and Analysis of Financial Condition or Plan of Operations Item 3 - Controls and Procedures PART II - OTHER INFORMATION Item 2 - Changes in Securities and Use of Proceeds Item 6 - Exhibits and Reports on Form 8-K SIGNATURES F-2 PART I - FINANCIAL INFORMATION ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS The financial statements of the company are set forth beginning on page F-1. PART I - FINANCIAL INFORMATION ------------------------------ ITEM 1. FINANCIAL STATEMENTS AS USED HEREIN, THE TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT INC. UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL STATEMENTS INCLUDING A BALANCE SHEET FOR THE COMPANY AS OF THE QUARTER ENDED JUNE 30, 2006, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN BY THIS REFERENCE. [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY] F-2 CONSOLIDATED MINERALS MANAGEMENT, INC. (A MONTANA CORPORATION) CONSOLIDATED BALANCE SHEET (UNAUDITED) ASSETS ------ JUNE 30, 2006 DECEMBER 31, 2005 ------------------ -------------------- Current Assets -------------- Cash $ -0- $ -0- ------------------ -------------------- Total Current Assets -0- -0- Oil & Gas Properties - Non Producing 60,000 60,000 Notes Receivable 2,506,000 2,506,000 Investment in Intercontinental Fuel, LLC 1,600,000 1,600,000 ------------------ -------------------- Total Assets $ 4,166,000 $ 4,166,000 ================== ===================== LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) ---------------------------------------------- Current Liabilities ------------------- Accounts Payable & Accrued Expenses 583,536 469,536 Debentures & Notes Payable 500,000 500,000 ------------------ -------------------- Total Current Liabilities 1,083,536 969,536 Notes Payable - Long Term Portion 0 0 Debenture Payable - Dr. Zehr 2,000,000 2,000,000 Note Payable - Dr. Zehr 600,000 600,000 ------------------ -------------------- Total Long-Term Liabilities 2,600,000 2,600,000 Total Liabilities $ 3,683,536 $ 3,569,536 Commitments and Contingencies: - -------------------- Stockholders' Equity -------------------- Preferred Stock 20,000,000 authorized shares, par value $.001 $ - $ - no shares issued and outstanding Common Stock 0.001 par value, 50,000,000 shares authorized 44,544,361 shares issued and outstanding as of June 30, 2006, 2006 and 44,544 44,544 44,544,223 shares issued and outstanding as of December 31, 2005. Additional Paid-in-Capital 4,332,172 4,332,172 Retained Earnings (Deficit) (3,894,252) (3,780,252) ------------------ -------------------- Total Stockholders' Equity (Deficit) 482,464 596,464 ------------------ -------------------- Total Liabilities and Stockholders' Equity (Deficit) $ 4,166,000 $ 4,166,000 ================== ===================== F-3 CONSOLIDATED MEDICAL MANAGEMENT, INC. (A MONTANA CORPORATION) CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, -------------------------------- ------------------------------- 2006 2005 2006 2005 - -------------- --------------- --------------- --------------- Revenues $ - $ - $ - $ - -------- Operating Expenses Consulting 57,000 57,000 114,000 114,000 Other Expenses 0 1,965 0 5,505 --------------- --------------- --------------- --------------- Total Operating Expenses $ 57,000 $ 58,965 $ (114,000) $ (119,505) Income (Loss) from Operations (57,000) (58,965) (114,000 (119,505) Other Income (Expenses) Interest Expense 0 -0- 0 0 --------------- --------------- --------------- --------------- Income (Loss) before Income Taxes $ (57,000) $ (58,965) $ (114,000) $ (119,505) Income Tax Expense - - - - --------------- --------------- --------------- --------------- Net Income (Loss) $ (57,000) $ (58,965) $ (114,000) $ (119,505) =============== =============== =============== =============== Net Income (Loss)/Share $ (0.001 ) $ (0.001) (.0025) (.027) =============== =============== =============== =============== F-4 CONSOLIDATED MEDICAL MANAGEMENT, INC. (A MONTANA CORPORATION) CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) SIX MONTHS ENDED JUNE 30, 2006 2005 ------------------------- Cash Flows from Operating Activities: Net Income (Loss) $ (57,000) $( 58,965) Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities: Depreciation and Amortization - - Non Cash Consulting and Services Paid by Stock Issue - - (Increase) Decrease in Receivables - - (Decrease) Increase in Accounts Payable & Accrued Expenses 57,000 58,982 (Increase) Decrease in Interest Payable - ------------- ---------- Net Cash Provided (Used) by Operating Activities $ -0- $ 17 ------------- ---------- Cash Flows from Investing Activities: ------------------------------------- 0 Note Receivable - Collections - - Oil & Gas Properties - Non Producing - ------------- ---------- Net Cash Provided (Used) by Investing Activities $ 0 $ - ------------- ---------- Cash Flows from Financing Activities: ------------------------------------- Proceed from Notes Payable - - Common Stock 0 - ------------- ---------- Net Cash Provided (Used) by Financing Activities $ 0 $ - ------------- ---------- Net Increase (Decrease) in Cash $ -0- $ 17 Cash, Beginning of period -0- 403 ------------- ---------- Cash, End of period $ -0- $ 420 F-5 NOTE 1 - BASIS OF PRESENTATION GENERAL ------- The consolidated unaudited interim financial statements of the Company as of June 30, 2006 and for the six months ended June 30, 2006, included herein have been prepared in accordance with the instructions for Form 10QSB under the Securities Exchange Act of 1934, as amended, and Article 10 of Regulation S-X under the Securities Act of 1933, as amended. The December 31, 2005 Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations relating to interim consolidated financial statements. In the opinion of management, the accompanying consolidated unaudited financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company at June 30, 2006 and 2005, and their respective cash flows for the six months ended June 30, 2006 and 2005. The results of operations for such periods are not necessarily indicative of results expected for the full year or for any future period. These financial statements should be read in conjunction with the audited consolidated financial statements as of December 31, 2005 and related notes included in the Company's Form 10-KSB filed with the Securities and Exchange Commission. ORGANIZATION CMMI was originally incorporated as a mining company. In 1985, the Company ceased its mining operations and discontinued all business operations in 1990. During 1998, since the acquisition of Consolidated Medical Management, Inc. (Louisiana) the Company initially focused its efforts on the continuation of the business services offered by CMMI-LA. These services focused on the delivery of turn-key management services for the home health industry, predominately in south Louisiana. The Company exited the medical business in December of 2000 and in August 2001 the Company decided to refocus on the oil and gas industry. CMMI has since decided to narrow its focus on the fuel distribution and terminal business and the related opportunities that may create. F-6 NOTES TO FINANCIAL STATEMENTS NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES --------------------------------------------------- ACCOUNTING METHOD ----------------- Accounting policies of the Company conform to the generally accepted accounting principles and reflect practices appropriate to the industry in which it operates. The significant policies are summarized below. CASH FLOWS AND CONCENTRATION OF CREDIT RISK ------------------------------------------- Cash consists principally of demand deposits at commercial banks. These balances, as reflected in the bank's records, are insured by the Federal Deposit Insurance Corporation up to $100,000. At December 31, 2005 and June 30, 2006, the Company's deposits did not exceed the insured limits. EARNINGS PER COMMON SHARE ------------------------- The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per Share," which simplifies the computation of earnings per share requiring the restatement of all prior periods. Basic earnings per share are computed on the basis of the weighted average number of common shares outstanding during each year. Diluted earnings per share are computed on the basis of the weighted average number of common shares and dilutive securities outstanding. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation. The Company does not have any dilutive securities as of June 30, 2006. CRITICAL ACCOUNTING POLICIES AND ESTIMATES The preparation of financial statements requires management to make estimates and assumptions that affect reported earnings. The estimates and assumptions are evaluated on an on-going basis and are based on historical experience and on other factors that management believes are reasonable. Estimates and assumptions include, but are not limited to commitments and contingencies. The Company believes that the following represent the areas where more critical estimates and assumptions are used in the preparation of the financial statements: LONG-LIVED ASSET IMPAIRMENTS: The Company records impairments when the carrying amounts of long-lived assets are determined not to be recoverable. Impairment is assessed and measured by an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. Changes in market conditions can impact estimated future cash flows from use of these assets and impairment charges may be required should such changes occur. F-7 NOTES TO FINANCIAL STATEMENTS NOTE 3 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE ------------------------------------------------- The Company issued Debenture No 299 in the amount of $350,000 on April 15, 2003. The Debenture bears interest at the rate of 5% per annum and matures on October 15, 2003. The debenture is in default. The Company issued Convertible Debenture No 300 on April 15, 2003. The debenture bears interest at the rate of 5% per annum and matures on April 15, 2006. The debenture is convertible after April 15, 2004 into $2,000,000 of common stock at a cost per share of seventy per cent of the average bid price for the stock for the immediate twenty (20) days before exercise. NOTE 4 - COMMON AND PREFERRED STOCK ----------------------------------- COMMON STOCK ------------ The Company's common stock is $0.001 par value, there are 50,000,000 shares authorized as of December 31, 2005 and June 30, 2006, the Company had 44,544,361 and 44,544,223 shares issued and outstanding, respectively. PREFERRED STOCK --------------- In 1998, the Company amended its articles to authorize Preferred Stock. There are 20,000,000 shares authorized with a par value of $ 0.001. The shares are non-voting and non-redeemable by the Company. The Company further designated two series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with 2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred Stock," with the number of authorized shares set at 1,079,957 shares. As of June 30, 2006 and December 31, 2005 there are no shares issued and outstanding. DIVIDENDS --------- Dividends are non-cumulative, however, the holders of such series, in preference to the holders of any common stock, shall be entitled to receive, as and when declared payable by the Board of Directors from funds legally available for the payment thereof, dividends in lawful money of the United States of America at the rate per annum fixed and determined as herein authorized for the shares of such series, but no more, payable quarterly on the last days of March, June, September, and December in each year with respect to the quarterly period ending on the day prior to each such respective dividend payment date. In no event shall the holders of either series receive dividends of more than percent (1%) in any fiscal year. Each share of both series shall rank on parity with each other share of preferred stock, irrespective of series, with respect to dividends at the respective fixed or maximum rates for such series. F-8 NOTES TO FINANCIAL STATEMENTS CONVERSION PROVISIONS --------------------- Any holder of either series may convert any or all of such shares into shares of common stock of the Company at any time. Said shares shall be convertible at a rate equal to three (3) shares of common stock of the Company for each one (1) share of Series "A" of $ 12.50 Preferred Stock. The Series "A" $12.50 Preferred Stock shall be convertible, in whole or in part, at any time after the common stock of the Company shall maintain an average bid price per share of at least $12.50 for ten (10) consecutive trading days. Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three (3) shares of common stock of the Company for each one (1) share of Series "A" $8.00 Preferred Stock. The Series "A" $8.00 Preferred Stock shall be convertible, in whole or in part, at any time after the common stock of the Company shall maintain an average bid price per share of at least $8.00 for ten (10) consecutive trading days. The preferential amount payable with respect to shares of either Series of Preferred Stock in the event of voluntary or involuntary liquidation, dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus the amount of any dividends declared and unpaid thereon. NOTE 5 - COMMITMENT AND CONTINGENCIES The Company has not recognized any commitments or contingencies at this time. The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash, nor does it have an established source of revenues sufficient to cover its operating costs raising substantial doubt about its ability to continue as a going concern. F-9 ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATIONS. The following discussion should be read in conjunction with our unaudited consolidated interim financial statements and related notes thereto included in this quarterly report and in our audited consolidated financial statements and Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31, 2005. Certain statements in the following MD&A are forward looking statements. Words such as "expects", "anticipates", "estimates" and similar expressions are intended to identify forward looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. GENERAL Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws of the State of Montana on August 13, 1981 under the name Golden Maple Mining and Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated Medical Management, Inc. In August 2001, the Company decided to refocus on the oil and gas industry and are currently doing business as Consolidated Minerals Management, Inc. CMMI's address was 7500 San Felipe, Suite 600, Houston, Texas 77063. In July 2003 the Company moved its offices to 11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816. RESULTS OF OPERATIONS For the quarter ended June 30, 2006, CMMI incurred a net loss of $ (57,000). The loss in entirely attributable to accrual of expenses incurred for consultants. COMPARISON OF QUARTER ENDED JUNE 30, 2006 TO THE QUARTER ENDED JUNE 30, 2005 For the quarter ended June 30, 2006, our net loss was $ (57,000) as compared to $(58,982) for the quarter ended June 30, 2005. The loss is attributable to the accrual of consulting costs incurred in the second quarter. LIQUIDITY AND CAPITAL RESOURCES Currently, the liabilities shown on the balance sheet are current trade payables and accrued expenses incurred in the normal course of business. Continuing negative operating results produced a working capital deficit . The Company's recurring negative financial results raise substantial doubt about the Company's ability to continue as a going concern. The Company will need to raise additional funds through additional debt or equity financing. There can be no assurance that additional equity or debt financing will be available when needed or on terms acceptable to the Company. The market price of the Company's common stock has fluctuated significantly since it began to be publicly traded in 1998 and may continue to be highly volatile. Factors such as the ability of the Company to achieve development goals, ability of the Company to profitably complete energy projects, the ability of the Company to raise additional funds, general market conditions and other factors affecting the Company's business that are beyond the Company's control may cause significant fluctuations in the market price of the Company's common stock. The market prices of the stock of many energy companies have fluctuated substantially, often unrelated to the operating or research and development performance of the specific companies. Such market fluctuations could adversely affect the market price for the Company's common stock. F-10 CRITICAL ACCOUNTING POLICIES AND ESTIMATES The Company's discussion and analysis of its financial condition and results of operations are based upon its consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates and assumptions provide a basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and these differences may be material. FORWARD-LOOKING INFORMATION - GENERAL This report contains a number of forward-looking statements, which reflect the Company's current views with respect to future events and financial performance including statements regarding the Company's projections. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated. In this report, the words "anticipates", "believes", "expects", "intends", "future", "plans", "targets" and similar expressions identify forward-looking statements. Readers are cautioned to not place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof the Company undertakes no obligation to publicly revise these forward-looking statements, to reflect events or circumstances that may arise after the date hereof. Additionally, these statements are based on certain assumptions that may prove to be erroneous and are subject to certain risks including, but not limited to, the Company's dependence on limited cash resources, and its dependence on certain key personnel within the Company. Accordingly, actual results may differ, possibly materially, from the predictions contained herein. ITEM 3. CONTROLS AND PROCEDURES. Timothy G. Byrd, Sr., our Chief Executive Officer and Acting Chief Accounting Officer, has concluded that our disclosure controls and procedures are appropriate and effective. He has evaluated these controls and procedures as of a date within 90 days of the filing date of this report on Form 10-QSB. There were no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. F-11 PART II Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5 are omitted. ITEM 2. CHANGES IN SECURITIES NONE. The following information sets forth certain information for all securities the Company issued from January 1, 2006 through June 30, 2006, in transactions without registration under the Act. There were no underwriters in any of these transactions, nor were any sales commissions paid thereon. The securities were issued pursuant to Section 4(2) of the Act. There were no new issuances in the second quarter of 2006. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. None ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K EXHIBIT INDEX EXHIBIT 31.1 Certification of Chief Executive Officer pursuant to Rule 15d-14(a) of the Exchange Act EXHIBIT 31.2 Certification of Chief Financial Officer pursuant to Rule 15d-14(a) of the Exchange Act. EXHIBIT 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, with respect to the registrant's quarterly report on Form 10QSB for the quarter ended June, 2006 EXHIBIT 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 Of the Sarbanes Oxley Act of 2002, with respect to the Registrant's quarterly report on Form 10QSB for the quarter Ended June 30, 2006. F-12 SIGNATURES Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on its behalf by the undersigned, there unto duly authorized, in the City of Baton Rouge, Louisiana, on August 20, 2006. CONSOLIDATED MEDICAL MANAGEMENT, INC. By: /s/ Timothy G. Byrd, Sr. --------------------------- Timothy G. Byrd, Sr. Chief Executive Officer, Acting Chief Accounting Officer, and Director F-13